Oxford Asset Management’s VolitionRx Ltd VNRX Stock Holding History

Oxford Asset Management’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-613	Closed	-$58K	–	1281
2019 Q4	$58K	Buy	+613	New	+$63.6K	﹤0.01%	1659

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Oxford Asset Management's VNRX Position: Q1 2020 in Review

Oxford Asset Management sold out of VolitionRx Ltd (VNRX) in Q1 2020, closing a stake of 613 shares — an estimated $58K sold.

Oxford Asset Management first reported a position in VNRX in Q4 2019 and held it in 1 quarter. The position peaked at $58K in Q4 2019. 31 funds tracked by Wall St. Rank hold VNRX as of Q1 2020.

Oxford Asset Management reported no remaining VolitionRx Ltd position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 613 VolitionRx Ltd shares in Q1 2020, an estimated $58K.
Oxford Asset Management first reported a position in VolitionRx Ltd in Q4 2019 and held it in 1 quarter.
Oxford Asset Management's VolitionRx Ltd position peaked at $58K in Q4 2019.
31 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.